<DOC>
	<DOCNO>NCT00048360</DOCNO>
	<brief_summary>This placebo control study evaluate efficacy safety medication adult Attention-Deficit Hyperactivity Disorder ( ADHD ) .</brief_summary>
	<brief_title>Attention-Deficit Hyperactivity Disorder ( ADHD ) Study With Adults</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Attention Deficit Disorder Hyperactivity</mesh_term>
	<mesh_term>Hyperkinesis</mesh_term>
	<mesh_term>Bupropion</mesh_term>
	<criteria>Inclusion criterion : Patient must diagnose ADHD . Patient current past history seizure disorder , brain injury , anorexia nervosa bulimia . Patient current diagnosis Major Depressive Disorder ( MDD ) . Patient current primary diagnosis , receive treatment , Panic Disorder , Obsessive Compulsive Disorder ( OCD ) , Posttraumatic Stress Disorder ( PTSD ) Acute Stress Disorder within previous 12 month . Patient lifetime diagnosis bipolar disorder , schizophrenia psychotic disorder . Patient positive urine test screen presence illicit drug alcohol abuse past 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>ADD</keyword>
	<keyword>ADHD</keyword>
	<keyword>attention deficit</keyword>
	<keyword>hyperactivity</keyword>
</DOC>